Adrien Herlédan

899 total citations
21 papers, 441 citations indexed

About

Adrien Herlédan is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Adrien Herlédan has authored 21 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Infectious Diseases and 3 papers in Cell Biology. Recurrent topics in Adrien Herlédan's work include Tuberculosis Research and Epidemiology (3 papers), Biochemical and Molecular Research (3 papers) and Cancer therapeutics and mechanisms (3 papers). Adrien Herlédan is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Biochemical and Molecular Research (3 papers) and Cancer therapeutics and mechanisms (3 papers). Adrien Herlédan collaborates with scholars based in France, United States and Italy. Adrien Herlédan's co-authors include Audrey Castet, Jean-Marc Vanacker, Sandrine Bonnet, Vincent Cavaillès, Stéphan Jalaguier, Benoît Déprez, Florence Leroux, Catherine Piveteau, Vehary Sakanyan and Norma B. Romero and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Adrien Herlédan

19 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Herlédan France 12 260 63 63 58 55 21 441
Jaeok Park Canada 17 516 2.0× 134 2.1× 56 0.9× 44 0.8× 34 0.6× 30 799
Robert R. Lavieri United States 11 440 1.7× 60 1.0× 61 1.0× 114 2.0× 36 0.7× 17 685
Albert S. Reger United States 13 515 2.0× 49 0.8× 40 0.6× 35 0.6× 17 0.3× 16 610
John T. Herberg United States 12 369 1.4× 34 0.5× 36 0.6× 33 0.6× 105 1.9× 19 493
Darren Bentley Switzerland 12 272 1.0× 146 2.3× 54 0.9× 18 0.3× 23 0.4× 24 532
Jun Young Jang South Korea 14 330 1.3× 54 0.9× 53 0.8× 13 0.2× 23 0.4× 24 627
Guadalupe Domínguez-Gómez Mexico 16 373 1.4× 135 2.1× 28 0.4× 33 0.6× 13 0.2× 38 678
Ruchi Shukla India 16 439 1.7× 72 1.1× 90 1.4× 23 0.4× 14 0.3× 43 759
Amit Ketkar United States 17 432 1.7× 60 1.0× 41 0.7× 24 0.4× 17 0.3× 30 603
Sudheer Bobba United States 8 206 0.8× 26 0.4× 24 0.4× 72 1.2× 12 0.2× 13 337

Countries citing papers authored by Adrien Herlédan

Since Specialization
Citations

This map shows the geographic impact of Adrien Herlédan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Herlédan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Herlédan more than expected).

Fields of papers citing papers by Adrien Herlédan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Herlédan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Herlédan. The network helps show where Adrien Herlédan may publish in the future.

Co-authorship network of co-authors of Adrien Herlédan

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Herlédan. A scholar is included among the top collaborators of Adrien Herlédan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Herlédan. Adrien Herlédan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herlédan, Adrien, et al.. (2026). ERAP2 inhibitor −incorporated nanofibers: Characterization and biological assessment. International Journal of Pharmaceutics. 690. 126555–126555.
2.
Landry, Valérie, Lowiese Desmarets, François‐Xavier Cantrelle, et al.. (2024). N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease. European Journal of Medicinal Chemistry. 276. 116707–116707. 1 indexed citations
3.
Plé, Coline, Giuseppe Sicoli, Ravil R. Petrov, et al.. (2024). Small molecule MarR modulators potentiate metronidazole antibiotic activity in aerobic E. coli by inducing activation by the nitroreductase NfsA. Journal of Biological Chemistry. 300(7). 107431–107431.
4.
Hennuyer, Nathalie, Isabelle Duplan, Emmanuelle Vallez, et al.. (2024). Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver. British Journal of Pharmacology. 181(19). 3610–3626. 6 indexed citations
5.
Heuson, Egon, Adrien Herlédan, Frédérik Oger, et al.. (2023). High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry. Cells. 12(6). 849–849. 3 indexed citations
6.
Hanoulle, Xavier, Valérie Landry, Danai Moschidi, et al.. (2023). Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses. European Journal of Medicinal Chemistry. 250. 115186–115186. 12 indexed citations
7.
Plé, Coline, Heng-Keat Tam, Juan-Carlos Jiménez-Castellanos, et al.. (2022). Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nature Communications. 13(1). 115–115. 46 indexed citations
8.
Hamela, Claire, Rudy Antoine, Adrien Herlédan, et al.. (2022). Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases. Journal of Medicinal Chemistry. 65(24). 16651–16664. 14 indexed citations
9.
Wen, Xiaoan, Valérie Landry, Adrien Herlédan, et al.. (2021). Identification of indole-based activators of insulin degrading enzyme. European Journal of Medicinal Chemistry. 228. 113982–113982. 7 indexed citations
10.
Trivelli, Xavier, Hervé Drobecq, Delphine Beury, et al.. (2021). Rubrolone production by Dactylosporangium vinaceum: biosynthesis, modulation and possible biological function. Applied Microbiology and Biotechnology. 105(13). 5541–5551. 7 indexed citations
11.
Herlédan, Adrien, Florence Leroux, Catherine Piveteau, et al.. (2019). Drug Target Engagement Using Coupled Cellular Thermal Shift Assay—Acoustic Reverse-Phase Protein Array. SLAS DISCOVERY. 25(2). 207–214. 9 indexed citations
12.
Kemmer, Christian, Adrien Herlédan, Rosangela Frita, et al.. (2019). A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. European Journal of Medicinal Chemistry. 167. 426–438. 14 indexed citations
13.
Leroux, Florence, Damien Bosc, Terence Beghyn, et al.. (2019). Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European Journal of Medicinal Chemistry. 179. 557–566. 13 indexed citations
14.
Mendes, Tiago, Adrien Herlédan, Florence Leroux, et al.. (2019). High‐Content Screening for Protein‐Protein Interaction Modulators Using Proximity Ligation Assay in Primary Neurons. Current Protocols in Cell Biology. 86(1). e100–e100. 2 indexed citations
15.
Tatum, Natalie J., John W. Liebeschuetz, Jason C. Cole, et al.. (2017). New active leads for tuberculosis booster drugs by structure-based drug discovery. Organic & Biomolecular Chemistry. 15(48). 10245–10255. 20 indexed citations
16.
Hennuyer, Nathalie, Florence Leroux, Catherine Piveteau, et al.. (2017). Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance. Journal of Medicinal Chemistry. 60(10). 4185–4211. 52 indexed citations
17.
Mathieu, Anne‐Laure, Olivier Spérandio, Adrien Herlédan, et al.. (2014). Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737. SLAS DISCOVERY. 19(7). 1035–1046. 12 indexed citations
18.
Gauthier, Christophe, Guillaume Durand, Astrid Musnier, et al.. (2009). A highly sensitive near‐infrared fluorescent detection method to analyze signalling pathways by reverse‐phase protein array. PROTEOMICS. 9(24). 5446–5454. 20 indexed citations
19.
Bitoun, Marc, Anne‐Cécile Durieux, Bernard Prudhon, et al.. (2009). Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Human Mutation. 30(10). 1419–1427. 67 indexed citations
20.
Castet, Audrey, Adrien Herlédan, Sandrine Bonnet, et al.. (2006). Receptor-Interacting Protein 140 Differentially Regulates Estrogen Receptor-Related Receptor Transactivation Depending on Target Genes. Molecular Endocrinology. 20(5). 1035–1047. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaeok Park Breakdown of academic impact, for papers by Robert R. Lavieri Breakdown of academic impact, for papers by Albert S. Reger Breakdown of academic impact, for papers by John T. Herberg Breakdown of academic impact, for papers by Darren Bentley Breakdown of academic impact, for papers by Jun Young Jang Breakdown of academic impact, for papers by Guadalupe Domínguez-Gómez Breakdown of academic impact, for papers by Ruchi Shukla Breakdown of academic impact, for papers by Amit Ketkar Breakdown of academic impact, for papers by Sudheer Bobba
Rankless by CCL
2026